- FT NewsFT News
- Press releasesPress releases
- Events & ActivityEvents & Activity
- Eisai/Merck: doubling up, and down
- Patent payout boosts Danish growth to strongest in 11 years
- Biogen shares fall as it adds patients to Alzheimer’s medicine trials
- Celgene sales target cuts signal wider biotech blues
- Lockheed Martin leads biggest decliners on S&P 500
- Pharma recovers composure as price concerns ease
Biogen Inc (BIIB:NSQ) closed at 279.68, 14.49% above the 52 week low of 244.28 set on May 31, 2017.
244.28May 31 2017370.57Jan 26 2018
Markit short selling activity
|Market cap||58.89bn USD|
|EPS (TTM)||17.46 |
Data delayed at least 15 minutes, as of Mar 20 2018 20:00 BST.